Endometriosis: biomarker testing offers hope for earlier diagnosis
article
OA: closed
public-domain-us
AI-generated summary
Biomarker testing holds promise for improving the early diagnosis of endometriosis, potentially altering the course of patient physical and mental health.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Earlier endometriosis diagnosis and treatment can change the trajectory of physical and mental wellbeing, write Gail Busby and Sharan Uppal
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Comparison of physical examination, ultrasound techniques and magnetic resonance imaging for the diagnosis of deep infiltrating endometriosis: A systematic review and meta‑analysis of diagnostic accuracy studies 2020
- Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis 2024
- Validation of a Saliva Micro-RNA Signature for Endometriosis 2025
References (3)
- Comparison of physical examination, ultrasound techniques and magnetic resonance imaging for the diagnosis of deep infiltrating endometriosis: A systematic review and meta‑analysis of diagnostic accuracy studies via openalex
- Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis via openalex
- Validation of a Saliva Micro-RNA Signature for Endometriosis via openalex
Source provenance
- europepmc
- last seen: 2026-08-27T06:11:05.884134+00:00
- openalex
- last seen: 2026-08-27T06:01:51.984654+00:00
- pubmed
- last seen: 2026-08-27T06:03:54.189784+00:00
- unpaywall
- last seen: 2026-08-27T06:26:25.619941+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine